Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Prognostic Impact of t(4;11)(q21;q23)/ KMT2A-AFF1 -Positivity in 926 BCR-ABL1 -Negative B-Lineage Acute Lymphoblastic Leukemia Patients Treated in Gimema Clinical Trials Since 1996

Alfonso Piciocchi, Monica Messina, Loredana Elia, Bs, Antonella Vitale, MD, Stefano Soddu, Anna Maria Testi, MD, Sabina Chiaretti, MD PhD, Marco Mancini, MD, Giorgina Specchia, MD, Antonio Spadano, MD, Mauro Krampera, Roberto Cairoli, MD, Francesco Di Raimondo, MD, Felicetto Ferrara, MD, Giuseppe Cimino, MD, Renato Bassan, MD, Paola Fazi, MD, Marco Vignetti, MD

Blood (2019) 134 (Supplement_1): 1469.

https://doi.org/10.1182/blood-2019-121977

Published: 2019

Journal Articles

Impact of Induction Regimen and of Allogeneic Hematopoietic Cell Transplantation on the Outcome in Younger Adults Patients with Acute Myeloid Leukemia with a Monosomal Karyotype: Results from the EORTC/Gimema AML-10 and AML-12 Trials

Frederic Baron, MD PhD, Marian Stevens-Kroef, PhD, Giovanna Meloni, MD, Petra Muus, MD PhD, Jean-Pierre Marie, MD, Constantijn J.M. Halkes, MD PhD, Xavier Thomas, MD PhD, Radovan Vrhovac, MD PhD, Giorgina Specchia, MD, Francois Lefrere, Sr., MD, Simona Sica, Marco Mancini, MD, Adriano Venditti, MD, Anne Hagemeijer, MD, Joop H. Jansen, PhD, Sergio Amadori, MD, Theo de Witte, MD, Roelof Willemze, MD PhD, Stefan Suciu, PhD

Blood (2016) 128 (22): 2847.

https://doi.org/10.1182/blood.V128.22.2847.2847

Published: 2016

Journal Articles

Incidence of Severe (≤ 10g/dl) Chronic Anemia in Elderly Patients with Newly Diagnosed Chronic Myeloid Leukemia Treated with Imatinib and Role of Erythropoietin Therapy

Laura Cesini, MD, Ida Carmosino, Melissa Campanelli, MD, Massimo Breccia, MD, Maria Lucia De Luca, Gioia Colafigli, Matteo Molica, Fulvio Massaro, Federico Vozella, Daniela Diverio, PhD, Marco Mancini, MD, Giuliana Alimena, Roberto Latagliata, MD

Blood (2016) 128 (22): 1903.

https://doi.org/10.1182/blood.V128.22.1903.1903

Published: 2016

Journal Articles

Pulmonary Infections in Patients with Myelodysplastic Syndromes Receiving Azacytidine Treatment

Roberto Latagliata, MD, Pasquale Niscola, MD, Maria Antonietta Aloe Spiriti, MD, Ida Carmosino, Laura Cesini, MD, Chiara Sarlo, MD, Annalina Piccioni, MD, Alessia Campagna, MD, Maria Lucia De Luca, Federico Vozella, Melissa Campanelli, MD, Marco Mancini, MD, Massimo Breccia, MD, Giuseppe Avvisati, MD, Agostino Tafuri, MD, Paolo de Fabritiis, MD, Giuliana Alimena, MD, Corrado Girmenia, MD

Blood (2016) 128 (22): 5544.

https://doi.org/10.1182/blood.V128.22.5544.5544

Published: 2016

Journal Articles

Incidence of Late Chronic Anemia in Newly Diagnosed Patients with Chronic Myelogenous Leukemia Responsive to Imatinib

Paola Volpicelli, MD, Roberto Latagliata, MD, Massimo Breccia, Federico Vozella, Paola Finsinger, Ida Carmosino, Giuseppina Loglisci, MD, Michelina Santopietro, MD, Adriano Salaroli, Daniela Diverio, PhD, Marco Mancini, MD, Agostino Tafuri, Giuliana Alimena

Blood (2012) 120 (21): 3769.

https://doi.org/10.1182/blood.V120.21.3769.3769

Published: 2012

Journal Articles

Minor Erythroid Response and Decreased WT1 Expression After Proteasome Inhibition by Bortezomib in Myelodysplastic Syndromes (GIMEMA MDS0104 Phase II Trial).

Massimo Breccia, MD, Roberto Latagliata, MD, Laura Cannella, MD, Ida Carmosino, MD, Enrico Gottardi, Daniela Cilloni, MD, Marco Vignetti, MD, Michelina Santopietro, MD, Marco Mancini, MD, Giuliana Alimena, MD

Blood (2009) 114 (22): 1777.

https://doi.org/10.1182/blood.V114.22.1777.1777

Published: 2009

Journal Articles

Deletions of the Derivative Chromosome 9 Do Not Influence Response to Imatinib of Early Chronic Phase Chronic Myeloid Leukemia Patients (A GIMEMA Working Party Analysis).

Blood (2006) 108 (11): 2112.

https://doi.org/10.1182/blood.V108.11.2112.2112

Published: 2006

Journal Articles

Imatinib Mesylate Therapy in Late Ph+ Chronic Myeloid Leukemia Patients in Stable Complete Cytogenetic Response after Interferon-Alpha Results in a Very High Complete Molecular Response Rate.

Giuliana Alimena, MD, Massimo Breccia, MD, Luigia Luciano, MD, Fabrizio Quarantelli, PhD, Daniela Diverio, PhD, Barbara Izzo, MD, Biagio De Angelis, Marco Mancini, MD, Roberto Latagliata, MD, Ida Carmosino, MD, Mauro Nanni, PhD, Bruno Rotoli, MD, Franco Mandelli, MD, Fabrizio Pane, MD

Blood (2006) 108 (11): 2158.

https://doi.org/10.1182/blood.V108.11.2158.2158

Published: 2006

Journal Articles

Long Term Follow up on Patients with Ph-Abnormal Clones Emerged during Imatinib Therapy.

Elisabetta Abruzzese, MD, Alessandro Gozzetti, MD, Nicoletta Testoni, PhD, Alfonso Zaccaria, MD, Franca Radaelli, MD, Sara Galimberti, MD, Malgorzata M. Trawinska, MD, Marco Mancini, MD, Dario Ferrero, MD, Michela Salvio, MD, Federica Sora’, MD, Monica Crugnola, MD, Michele Cedrone, MD, Gianantonio Rosti, MD, Sergio Amadori, MD, Paolo de Fabritiis, MD, Michele Baccarani, MD

Blood (2006) 108 (11): 2116.

https://doi.org/10.1182/blood.V108.11.2116.2116

Published: 2006

Journal Articles

Interphase FISH Analysis Reveals High Frequence of Partial 6q Deletions in Adult Acute Lymphoblastic Leukemia (ALL) with Normal or Failed Karyotype.

Marco Mancini, MD, Paola Gaspari, Daniela Scappaticci, Raffaella Isidori, MS, Cristina Ariola, MS, Loredana Elia, MS, Fabrizio Pane, MD, Francesco Fabbiano, MD, Felicetto Ferrara, MD, Andrea Camera, MD, Caterina Musolino, MD, Luciana Annino, MD, Ruggero Mozzana, MD, Nicola Cantore, MD, Filippo Marmont, MD, Robin Foà, MD

Blood (2005) 106 (11): 1460.

https://doi.org/10.1182/blood.V106.11.1460.1460

Published: 2005

Journal Articles

Association of Hydroxyurea to Imatinib Is Effective in Patients with Chronic Myelogenous Leukemia Resistant to Imatinib Alone.

Roberto Latagliata, MD, Massimo Breccia, MD, Ida Carmosino, MD, Chiara Sarlo, MD, Rosa De Cuia, MD, Marco Mancini, MD, Francesca Biondo, MD, Eleonora Russo, MD, Annalisa De Vellis, MD, Daniela Diverio, MD, Franco Mandelli, PhD, Giuliana Alimena, PhD

Blood (2004) 104 (11): 4693.

https://doi.org/10.1182/blood.V104.11.4693.4693

Published: 2004

Journal Articles

Ph-Abnormal Clones Emerged during Imatinib Therapy: Clinical Report and Clonal Analyses on 23 Patients from GIMEMA Working Party (GWP) in CML Registry.

Elisabetta Abruzzese, MD, Alessandro Gozzetti, MD, Alfonso Zaccaria, MD, Nicoletta Testoni, MD, Sara Galimberti, MD, Malgorzata M. Trawinska, MD, Tommaso Caravita, MD, Paola Panetta, BS, Marco Mancini, MD, Dario Ferrero, MD, Michela Salvio, MD, Franca Radaelli, MD, Federica Sora’, MD, Gianantonio Rosti, Sergio Amadori, MD, Michele Baccarani, MD

Blood (2004) 104 (11): 2936.

https://doi.org/10.1182/blood.V104.11.2936.2936

Published: 2004

Journal Articles

Intensification of Post-Remissional Treatment in Adult Acute Lymphoblastic Leukemia (ALL) with t(4;11) or t(1;19): Results of the GIMEMA LAL 2000 Study.

Marco Vignetti, MD, Giovanna Meloni, MD, Monica Morselli, MD, Alessandra Tedeschi, MD, Felicetto Ferrara, MD, Nicola Cantore, MD, Giorgina Specchia, MD, Francesco Di Raimondo, MD, Anna Recchia, MD, Simona Sica, MD, Nicola Cascavilla, MD, Andrea Camera, MD, Francesco Fabbiano, MD, Giuseppe Cimino, MD, Marco Mancini, MD, Paola Fazi, MD, Roberto Foà, MD, Franco Mandelli, MD

Blood (2004) 104 (11): 4492.

https://doi.org/10.1182/blood.V104.11.4492.4492

Published: 2004

Journal Articles

Identification of a LOH Region on Chromosome 9p Associated with a Specific Gene Expression Signature in Adult B-Lineage ALL through Integration of High Density Microarray Expression and SNP Analyses.

Sabina Chiaretti, MD, Xiaochun Li, PhD, Robert Gentleman, PhD, Cheng Li, PhD, Antonella Vitale, MD, Marco Mancini, MD, Cristina Mecucci, MD, Robin Foa, MD, Jerome Ritz, MD

Blood (2004) 104 (11): 1119.

https://doi.org/10.1182/blood.V104.11.1119.1119

Published: 2004

Journal Articles

Heterogeneous Chromosomal Mechanisms Generating the 5′RUNX1/3′CBFA2T1 Gene in Acute Myeloid Leukemia.

Giorgina Specchia, MD, Francesco Albano, MD, Luisa Anelli, MD, Antonella Zagaria, MD, Arcangelo Liso, MD, Roberta La Starza, MD, Marco Mancini, MD, Antonio Cuneo, MD, Giuseppe Saglio, MD, Paola Fazi, MD, Nicoletta Testoni, MD, Laura Vicari, MD, Vincenzo Liso, MD, Mariano Rocchi, MD

Blood (2004) 104 (11): 4272.

https://doi.org/10.1182/blood.V104.11.4272.4272

Published: 2004

NARROW

Prognostic Impact of t(4;11)(q21;q23)/ KMT2A-AFF1 -Positivity in 926 BCR-ABL1 -Negative B-Lineage Acute Lymphoblastic Leukemia Patients Treated in Gimema Clinical Trials Since 1996

Impact of Induction Regimen and of Allogeneic Hematopoietic Cell Transplantation on the Outcome in Younger Adults Patients with Acute Myeloid Leukemia with a Monosomal Karyotype: Results from the EORTC/Gimema AML-10 and AML-12 Trials

Incidence of Severe (≤ 10g/dl) Chronic Anemia in Elderly Patients with Newly Diagnosed Chronic Myeloid Leukemia Treated with Imatinib and Role of Erythropoietin Therapy

Pulmonary Infections in Patients with Myelodysplastic Syndromes Receiving Azacytidine Treatment

Incidence of Late Chronic Anemia in Newly Diagnosed Patients with Chronic Myelogenous Leukemia Responsive to Imatinib

Minor Erythroid Response and Decreased WT1 Expression After Proteasome Inhibition by Bortezomib in Myelodysplastic Syndromes (GIMEMA MDS0104 Phase II Trial).

Deletions of the Derivative Chromosome 9 Do Not Influence Response to Imatinib of Early Chronic Phase Chronic Myeloid Leukemia Patients (A GIMEMA Working Party Analysis).

Imatinib Mesylate Therapy in Late Ph+ Chronic Myeloid Leukemia Patients in Stable Complete Cytogenetic Response after Interferon-Alpha Results in a Very High Complete Molecular Response Rate.

Long Term Follow up on Patients with Ph-Abnormal Clones Emerged during Imatinib Therapy.

Interphase FISH Analysis Reveals High Frequence of Partial 6q Deletions in Adult Acute Lymphoblastic Leukemia (ALL) with Normal or Failed Karyotype.

Association of Hydroxyurea to Imatinib Is Effective in Patients with Chronic Myelogenous Leukemia Resistant to Imatinib Alone.

Ph-Abnormal Clones Emerged during Imatinib Therapy: Clinical Report and Clonal Analyses on 23 Patients from GIMEMA Working Party (GWP) in CML Registry.

Intensification of Post-Remissional Treatment in Adult Acute Lymphoblastic Leukemia (ALL) with t(4;11) or t(1;19): Results of the GIMEMA LAL 2000 Study.

Identification of a LOH Region on Chromosome 9p Associated with a Specific Gene Expression Signature in Adult B-Lineage ALL through Integration of High Density Microarray Expression and SNP Analyses.

Heterogeneous Chromosomal Mechanisms Generating the 5′RUNX1/3′CBFA2T1 Gene in Acute Myeloid Leukemia.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only